Vaccinex (NASDAQ:VCNX) Trading 11.1% Higher – What’s Next?

Vaccinex, Inc. (NASDAQ:VCNX) traded up 11.1% on Tuesday . The company traded as high as $4.73 and last traded at $4.59. 166,955 shares changed hands during trading, an increase of 195% from the average session volume of 56,660 shares. The stock had previously closed at $4.13.

Vaccinex Price Performance

The business has a 50-day simple moving average of $3.16 and a two-hundred day simple moving average of $4.95. The stock has a market cap of $9.05 million, a price-to-earnings ratio of -0.08 and a beta of 1.10.

Hedge Funds Weigh In On Vaccinex

A hedge fund recently raised its stake in Vaccinex stock. Point72 Asset Management L.P. raised its position in shares of Vaccinex, Inc. (NASDAQ:VCNX) by 42.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 166,000 shares of the company’s stock after acquiring an additional 49,454 shares during the period. Point72 Asset Management L.P. owned approximately 9.60% of Vaccinex worth $564,000 at the end of the most recent quarter. 50.11% of the stock is owned by hedge funds and other institutional investors.

About Vaccinex

Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.